We are live on ! Find out more
UBS AM

UBS AM Portfolio holdings

AUM $481B
1-Year Est. Return 26.39%
 

UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.

This Fund
S&P 500
This Quarter Est. Return
+24.61%
1 Year Est. Return
+26.39%
3 Year Est. Return
+93.76%
5 Year Est. Return
+124.47%
10 Year Est. Return
+503.98%
AUM
$164B
AUM Growth
+$24.6B
Cap. Flow
-$6.16B
Cap. Flow %
-3.77%
Top 10 Hldgs %
24.12%
Holding
2,605
New
144
Increased
926
Reduced
1,290
Closed
142

Top Buys

Rank Stock Value
1
NTES icon
NetEase
NTES
+$336M
2
ABBV icon
AbbVie
ABBV
+$235M
3
VMW
VMware, Inc
VMW
+$163M
4
TMUS icon
T-Mobile US
TMUS
+$156M
5
APTV icon
Aptiv
APTV
+$154M

Top Sells

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$570M
2
MSFT icon
Microsoft
MSFT
+$506M
3
AAPL icon
Apple
AAPL
+$394M
4
ABT icon
Abbott
ABT
+$262M
5
INTC icon
Intel
INTC
+$244M

Sector Composition

Rank Sector Weight
1 Technology 22.77%
2 Healthcare 13.92%
3 Consumer Discretionary 13.52%
4 Financials 11.89%
5 Communication Services 9.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IMVT icon
2326
Immunovant
IMVT
$8.25B
$217K ﹤0.01%
+8,900
New +$191K
MCRI icon
2327
Monarch Casino & Resort
MCRI
$2.23B
$216K ﹤0.01%
+6,325
New +$210K
HA
2328
DELISTED
Hawaiian Holdings, Inc.
HA
$215K ﹤0.01%
15,280
-12,825
-46% -$175K
BMRC icon
2329
Bank of Marin Bancorp
BMRC
$459M
$214K ﹤0.01%
+6,412
New +$203K
GLRE icon
2330
Greenlight Captial
GLRE
$506M
$211K ﹤0.01%
32,321
-5,492
-15% -$35.9K
MATW icon
2331
Matthews International
MATW
$739M
$210K ﹤0.01%
10,993
-12,886
-54% -$275K
QCRH icon
2332
QCR Holdings
QCRH
$1.7B
$208K ﹤0.01%
+6,672
New +$192K
QSR icon
2333
Restaurant Brands International
QSR
$25.8B
$208K ﹤0.01%
+3,803
New +$192K
HIBB
2334
DELISTED
Hibbett, Inc. Common Stock
HIBB
$207K ﹤0.01%
+9,866
New +$164K
ASIX icon
2335
AdvanSix
ASIX
$444M
$206K ﹤0.01%
17,541
-8,429
-32% -$98.1K
CPF icon
2336
Central Pacific Financial
CPF
$1B
$203K ﹤0.01%
12,690
-11,869
-48% -$188K
CZZ
2337
DELISTED
Cosan Limited
CZZ
$203K ﹤0.01%
13,500
UI icon
2338
Ubiquiti
UI
$34.3B
$203K ﹤0.01%
1,163
-1,701
-59% -$285K
BALY icon
2339
Bally's
BALY
$658M
$203K ﹤0.01%
+9,100
New +$161K
LAC
2340
DELISTED
Lithium Americas Corp. Common Shares
LAC
$202K ﹤0.01%
39,400
+15,100
+62% +$56.2K
REX icon
2341
REX American Resources
REX
$1.41B
$202K ﹤0.01%
+17,454
New +$173K
ASTH icon
2342
Astrana Health
ASTH
$1.77B
$201K ﹤0.01%
12,181
-1,500
-11% -$23.6K
HY icon
2343
Hyster-Yale Materials Handling
HY
$665M
$200K ﹤0.01%
5,180
EIDX
2344
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
$200K ﹤0.01%
+4,200
New +$195K
WSR
2345
DELISTED
Whitestone REIT
WSR
$200K ﹤0.01%
27,515
-8,726
-24% -$55.5K
ACRE
2346
Ares Commercial Real Estate
ACRE
$270M
$198K ﹤0.01%
21,700
-10,363
-32% -$80.8K
ACBI
2347
DELISTED
Atlantic Capital Bancshares, Inc. Common Stock
ACBI
$195K ﹤0.01%
16,068
-10,163
-39% -$117K
BMY.RT
2348
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
$195K ﹤0.01%
54,567
-57,462
-51% -$207K
RIGL icon
2349
Rigel Pharmaceuticals
RIGL
$750M
$195K ﹤0.01%
10,671
-195
-2% -$3.51K
XENT
2350
DELISTED
Intersect ENT, Inc
XENT
$195K ﹤0.01%
14,398

Similar funds

UBS AM's Q2 2020 Portfolio in Review

As of Q2 2020, UBS AM held 2,605 positions worth $164B, up 18% from $139B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

UBS AM withdrew a net $6.16B in Q2 2020, closing 142 positions and reducing 1,290 holdings. Its most notable exit was Allergan plc, an estimated $203M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, UBS AM opened a new position in Otis Worldwide worth $76.5M.

  • UBS AM's largest Q2 2020 buy was Otis Worldwide: 1,345,382 shares worth $76.5M.
  • UBS AM added most to NetEase in Q2 2020, an estimated $336M increase.
  • UBS AM's biggest Q2 2020 reduction was Alibaba, cutting an estimated $570M.
  • UBS AM fully exited Allergan plc in Q2 2020, selling an estimated $203M.
  • UBS AM's ten largest holdings make up 24% of its $164B portfolio in Q2 2020.
  • UBS AM opened 144 new positions and closed 142 in Q2 2020.
  • UBS AM's portfolio value rose 18% quarter-over-quarter to $164B.

Based on UBS AM's 13F filing for Q2 2020, filed 14 Aug 2020.